Abstract:Background and Objectives. Epinephrine is frequently combined with local anesthesia to prolong analgesia. Determination of the minimal concentration and the dose of epinephrine that produces prolongation of analgesia is important in the face of epinephrine's potential for systemic and local toxicity. The authors undertook this study to determine a dose-response curve of epinephrine on duration of analgesia of both 1% lidocaine and 0.25% bupivacaine after local infiltration. In order to determine whether epinephrine-induced vasoconstriction affected duration of analgesia, the authors correlated duration of analgesia with magnitude of local vasoconstriction as measured with laser Doppler flowmetry. Methods. Six volunteers were studied in a randomized double-blind manner. Ten skin wheals of 0.2 mL solution were subcutaneously injected into both forearms of each volunteer. The solutions consisted of 1% lidocaine with epinephrine concentrations of 0, 1:50,000, 1:200,000, 1:800,000, and 1:3,200,000, and 0.25% bupivacaine with the same epinephrine concentrations. Duration of loss of sensation to pinprick at each wheal was recorded. Skin wheals with 0.2 mL of these same solutions were also subcutaneously injected into the abdomen of the same 6 volunteers, and laser Doppler flowmetry readings of skin blood flow were measured for 6 hours after injection. Results. Epinephrine prolonged duration of analgesia for both lidocaine and bupivacaine in a dose-related manner (P < .001). All concentrations of epinephrine attenuated the vasodilation observed in the first 15 minutes after injection with plain local anesthesia (P = .03), and blood flow returned to baseline by 30 minutes after injection of either plain or epinephrinecontaining solutions. Duration of analgesia correlated with magnitude of vasoconstriction only at the 15-minute measurement (r = .53 and .57, P= .003 and 0.001 for lidocaine and bupivacaine, respectively). Conclusions. Epinephrine prolongs duration of analgesia after local infiltration in a dose-related manner. Addition of epinephrine in concentrations of 1:50,000 or 1:200,000 increases duration of analgesia after local infiltration by approximately 200%. Addition of doses as dilute as 1:3,200,000 still increases duration of analgesia by approximately 100%. Duration of analgesia appears to correlate with magnitude of epinephrine-induced vasoconstriction using laser Doppler flowmetry. Based on study data, the use of epinephrine in concentrations from 1:200,000 to 1:3,200,000 is recommended for prolongation of analgesia after local infiltration.

Is the Foramen Caecum the Uppermost Part of the Spinal Medulla?

Electronically Powered Drug Delivery Devices: Considerations and Challenges

Epinephrine Prolongs Duration of Subcutaneous Infiltration of Local Anesthesia in a Dose-related Manner:: Correlation With Magnitude of Vasoconstriction

Advances in Wearable and Implantable Bioelectronics for Precision Medicine

Wearable and Implantable Electronics: Moving Toward Precision Therapy.

Recent advances in the development of flexible dye-sensitized solar cells: Fabrication, challenges and applications- A Review

Softening implantable bioelectronics: Material designs, applications, and future directions

Avian flu. Mild illnesses confound researchers.

Wireless Power and Data Transfer Technologies for Flexible Bionic and Bioelectronic Interfaces: Materials and Applications

Flexible electronic/optoelectronic microsystems with scalable designs for chronic biointegration.

Skin-inspired soft bioelectronic materials, devices and systems

Flexible Electronic/optoelectronic Microsystems with Scalable Designs for Chronic Biointegration

A system for bioelectronic delivery of treatment directed toward wound healing

Implantable Electronic Medicine Enabled by Bioresorbable Microneedles for Wireless Electrotherapy and Drug Delivery.

Materials and Devices for Biodegradable and Soft Biomedical Electronics

Barrier Materials for Flexible Bioelectronic Implants with Chronic Stability—current Approaches and Future Directions

Soft Bioelectronics for Therapeutics

Soft, Implantable Bioelectronic Interfaces for Translational Research

Materials for Flexible Bioelectronic Systems As Chronic Neural Interfaces

Wearable and Implantable Devices for Cardiovascular Healthcare: from Monitoring to Therapy Based on Flexible and Stretchable Electronics

Recent Progress in Implantable Drug Delivery Systems